New Members Appointed to LRG Board of Directors
The LRG welcomes three new members to its Board of Directors: Pat Bonda-Swenson, Santy DiSabatino and Bill Borwegen.
The LRG welcomes three new members to its Board of Directors: Pat Bonda-Swenson, Santy DiSabatino and Bill Borwegen.
Biomarker testing is an opportunity to improve and optimize treatment. In this post, GISTer Bill Borwegen shares his story and we share how you can help save lives.
GISTer Bill Borwegan shares his inspiring GIST journey illustrating the importance of biomarker/ mutational testing and self-advocacy as a rare disease patient.